Suchergebnisse - "Sébastien Perreault"

PubPharm (7)

1

LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration

in: BMC Cancer | 2024

von Cornelis M. van Tilburg | Lindsay B. Kilburn | Sébastien Perreault | +23

2

Intermittent neurologic decompensation: An underrecognized presentation of tyrosine hydroxylase deficiency

in: JIMD Reports | 2022

von Marjolaine Champagne | Gabriella A. Horvath | Sébastien Perreault | +4

3

Efficacy of Dabrafenib for three children with brainstem BRAFV600E positive ganglioglioma

enthalten in: Journal of neuro-oncology | 2019

von Philippe, L. | Maria, K. | Tariq, A. | +7

ErratumIn: J Neurooncol. 2019 Dec;145(3):595. - PMID 31768714

4

Efficacy of Dabrafenib for three children with brainstem $ BRAF^{V600E} $ positive ganglioglioma

enthalten in: Journal of neuro-oncology | 2019

von Philippe, L. | Maria, K. | Tariq, A. | +7

5

Efficacy of Dabrafenib for three children with brainstem $ BRAF^{V600E} $ positive ganglioglioma

enthalten in: Journal of neuro-oncology | 2019

von Philippe, L. | Maria, K. | Tariq, A. | +7

6

Efficacy of Dabrafenib for three children with brainstem $ BRAF^{V600E} $ positive ganglioglioma

enthalten in: Journal of neuro-oncology | 2019

von Philippe, L. | Maria, K. | Tariq, A. | +7

7

A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01

in: BMC Cancer | 2019

von Sébastien Perreault | Valérie Larouche | Uri Tabori | +16

1
[1]